Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.

D Milojkovic; NCP Cross; S Ali; J Byrne; G Campbell; FL Dignan; M Drummond; B Huntly; S Marshall; MF McMullin; P Neelakantan; M Raghavan; AJ Mead

doi:10.1111/bjh.16733

Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.

D Milojkovic, NCP Cross, S Ali, J Byrne, G Campbell, FL Dignan, M Drummond, B Huntly, S Marshall, MF McMullin, P Neelakantan, M Raghavan, AJ Mead

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	62-74
Journal	British Journal of Haematology
Volume	192
Issue number	1
DOIs	https://doi.org/10.1111/bjh.16733
Publication status	Published - May 2020

Access to Document

10.1111/bjh.16733

Cite this

Milojkovic, D., Cross, NCP., Ali, S., Byrne, J., Campbell, G., Dignan, FL., Drummond, M., Huntly, B., Marshall, S., McMullin, MF., Neelakantan, P., Raghavan, M., & Mead, AJ. (2020). Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study. British Journal of Haematology, 192(1), 62-74. https://doi.org/10.1111/bjh.16733

@article{1b1e7c4911d6493a981e83f97abf2bbd,

title = "Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.",

author = "D Milojkovic and NCP Cross and S Ali and J Byrne and G Campbell and FL Dignan and M Drummond and B Huntly and S Marshall and MF McMullin and P Neelakantan and M Raghavan and AJ Mead",

year = "2020",

month = may,

doi = "10.1111/bjh.16733",

language = "English",

volume = "192",

pages = "62--74",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley",

number = "1",

}

Milojkovic, D, Cross, NCP, Ali, S, Byrne, J, Campbell, G, Dignan, FL, Drummond, M, Huntly, B, Marshall, S, McMullin, MF, Neelakantan, P, Raghavan, M & Mead, AJ 2020, 'Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.', British Journal of Haematology, vol. 192, no. 1, pp. 62-74. https://doi.org/10.1111/bjh.16733

TY - JOUR

T1 - Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.

AU - Milojkovic, D

AU - Cross, NCP

AU - Ali, S

AU - Byrne, J

AU - Campbell, G

AU - Dignan, FL

AU - Drummond, M

AU - Huntly, B

AU - Marshall, S

AU - McMullin, MF

AU - Neelakantan, P

AU - Raghavan, M

AU - Mead, AJ

PY - 2020/5

Y1 - 2020/5

UR - http://europepmc.org/abstract/med/32449159

U2 - 10.1111/bjh.16733

DO - 10.1111/bjh.16733

M3 - Article

C2 - 32449159

SN - 0007-1048

VL - 192

SP - 62

EP - 74

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 1

ER -